Healthcare and wellness brands operate in the strictest content-compliance environment of any consumer category in 2026. The FTC’s Health Products Compliance Guidance requires “competent and reliable scientific evidence” for every health-related claim, and the agency has been increasingly aggressive about supplement, telehealth, and wellness advertising enforcement. Yet healthcare and wellness audiences are also the most receptive to authentic, peer-recommended content — and the most skeptical of polished brand advertising. This combination makes clipping uniquely well-suited to the category, provided the compliance layer is built into the campaign architecture from day one. This guide is the playbook: the regulatory framework healthcare brands need to operationalize through clipping briefs, the trust signals that move skeptical audiences, and CPM benchmarks across the major healthcare and wellness sub-categories. For the broader compliance context, see brand safety in clipping campaigns.
Calculate compliant-campaign economics. Use the clipping fee calculator.
- The 2026 Healthcare Advertising Framework
- Sub-Category Rules: Supplements, Telehealth, Wellness Apps, Devices
- The Trust Signals Healthcare Audiences Require
- CPM Benchmarks by Healthcare Vertical
- FAQ
The 2026 Healthcare Advertising Framework
| Framework | What It Regulates | Surface It Applies To |
|---|---|---|
| FDA (21 CFR 101.93) | Structure/function claims on dietary supplements; disease claims prohibited unless drug-approved | Product labels, websites, marketing collateral |
| FTC (“competent and reliable scientific evidence”) | All health-benefit claims in advertising; net impression rule applies | Ads, social posts, influencer content, clipping content |
| FTC 16 CFR Part 255 (Endorsement Guides) | Disclosure of material connections; “typical results” requirements for testimonials | Any paid endorsement, including clippers |
The FTC’s “net impression” rule is the trap that catches most wellness brands. Even if every individual word in a clip is technically compliant, the combination of visuals, voiceover, and on-screen text can create an overall deceptive impression. Brands need a compliance reviewer evaluating the whole clip, not just the script. The structural workflow matches the general briefing template with regulatory overlays.
Sub-Category Rules: Supplements, Telehealth, Wellness Apps, Devices
| Sub-Category | Permitted Claims | Prohibited Claims | Required Disclosures |
|---|---|---|---|
| Dietary supplements | Structure/function (“supports”, “helps maintain”, “promotes”) | Disease treatment, prevention, cure | DSHEA disclaimer, individual results disclaimer |
| Telehealth services | Service availability, licensed providers, general health education | Specific treatment outcomes without substantiation, off-label drug promotion | Provider licensing disclosure, state availability |
| Wellness apps (mental health, fitness) | App functionality, user experience, general wellness benefits | Medical diagnosis claims, replacement-for-therapy language | Not-medical-advice disclaimer for mental health apps |
| Medical devices (consumer-grade) | Cleared use cases per FDA 510(k) | Off-label uses, indications not in clearance | FDA clearance reference where applicable |
Supplements are the most heavily restricted category. The FTC has prioritized enforcement in weight-loss, immunity, and cognitive-enhancement. Brands need a pre-approved claim library clippers must use verbatim. Telehealth has expanded significantly — GLP-1 programs, mental health, dermatology — but the FTC’s 2025 actions against NextMed signal aggressive enforcement. Wellness apps occupy a more flexible position and are the highest-velocity sub-category. See mobile tactics in clipping for mobile app marketers.
The Trust Signals Healthcare Audiences Require
1. Credentialed source. Clips featuring an MD, ND, RD, PhD, or licensed therapist convert 3 to 5x higher. Include one 10-20 minute credentialed expert recording per quarter.
2. Specific ingredient or mechanism explanation. Generic claims (“our product works”) convert poorly. Specific claims (“our magnesium glycinate uses the chelated form that absorbs 4x better than magnesium oxide”) convert significantly higher.
3. Clinical or third-party validation reference. Specific study, clinical trial, or testing certification (NSF, USP, ConsumerLab). Must be accurate and substantiable.
4. Honest limitation acknowledgment. “This is not a replacement for medication if you have clinical depression” performs better than “our app will transform your mental health.” Audiences punish overselling and reward honesty.
5. Founder origin story. Why this brand exists. What problem the founder personally encountered. Especially strong in healthcare because audiences want human accountability behind health products.
CPM Benchmarks by Healthcare Vertical
| Vertical | CPM Range | Typical ROAS | Compliance Tier |
|---|---|---|---|
| Wellness apps (fitness, meditation, habit) | $2.00-$3.50 | 3-5x | Low |
| Dietary supplements (general) | $2.50-$4.00 | 3-6x | High |
| Dietary supplements (high-risk: weight loss, sexual health) | $3.00-$5.00 | 2-4x | Very high |
| Telehealth (general) | $3.50-$5.00 | 4-7x | Medium |
| Telehealth (GLP-1, dermatology) | $4.50-$6.00 | 5-10x | Very high |
| Mental health apps | $3.00-$4.50 | 3-5x | Medium |
| Consumer medical devices | $3.50-$5.00 | 3-6x | High |
| Beauty / skincare (with health claims) | $2.50-$4.00 | 3-7x | Medium |
For healthcare and wellness brands in 2026, Reach.cat provides: pre-publication approval with compliance reviewer workflow, FTC-aligned brief templates, structure/function claim libraries, and CPM rates of $2 to $6 across supplements, telehealth, wellness apps, and consumer medical devices.
Can supplement brands run clipping campaigns in 2026?
Yes, with disciplined compliance architecture: pre-approved structure/function claims, prohibited disease claims, DSHEA disclaimers, FTC “typical results” requirements. Brands with documented claim substantiation files and compliance reviewers can scale successfully. Brands that improvise invite FTC exposure.
What disclosures are required on healthcare clipping content?
Three layers: (1) FTC #ad disclosure tag. (2) Category-specific disclaimers — DSHEA for supplements, “not medical advice” for wellness apps, individual results for testimonials. (3) State availability disclosure for telehealth. High-risk claims: on-screen disclaimers recommended in addition to caption.
Why are healthcare audiences harder to convert?
Healthcare purchases involve entrusting a brand with your health, not just your money. The five trust signals directly address this skepticism. Brands building these into source content convert 2 to 5x better than brands relying on standard product-demo formats.
Are telehealth services a good fit for clipping?
Yes. One of the strongest-performing verticals in 2026. GLP-1 programs and dermatology: LTV $300-$1,000+/month, 5-10x ROAS. Compliance load is significant but unit economics justify the investment.
How do I handle before/after content compliantly?
“Results vary” alone is insufficient if the overall impression suggests typical results. Limit before/after to documented clinical study averages, use multiple subjects, include on-screen typical-results data alongside the visual.
Healthcare Clipping Is a Compliance Engineering Problem With a High-ROAS Payoff.
Build the brief correctly. Pre-approve claim language. Add compliance reviewer. Embed trust signals in source content. Wellness apps at 3-5x ROAS, telehealth at 4-10x, supplements at 3-6x when handled compliantly. The compliance is the difference between scale and exposure.